Medtronic (MDT)

Intuitive Surgical remains in focus as analysts weigh reprocessing risks after Restore Robotics secures FDA clearance for remanufactured tools.

Steady growth and dividend increases over decades can make investors remarkably wealthy.

As firms continue releasing financial results late into the calendar Q1 earnings season, announcements of dividend increases also continue. Some of the latest announcements are particularly notable. This is because several companies that already have high-dividend yield stocks are increasing their quarterly payments even more.

MEDTRONIC PLC (NYSE:MDT) offers a solid 3.45% dividend yield with a reliable payout history, strong profitability, and reasonable valuation, making it a compelling choice for dividend investors.

The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions.

The company said the regulatory path forward for one of its key systems is too murky to pursue.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.

Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.

U.S. equities trading was mixed on Wednesday, with major indices showing limited movement by midday as investors remained cautious amid renewed concerns over fiscal policy, which pressured Treasury bonds and the dollar.

Moderna will resubmit the application later this year after data from its ongoing late-stage trial of its seasonal flu vaccine is available.

For the second quarter, XPeng expects to deliver between 102,000 and 108,000 vehicles, representing a YoY increase of as much as 257.5%.

The company beat quarterly expectations and issued strong earnings guidance. But the spinoff plans sent shares lower.